CION Ameerpet
Burkitt lymphoma is one of the fastest-growing childhood cancers — and also one of the most treatable. This guide explains the signs, how it is diagnosed and staged, and how CION coordinates prompt, specialist care for a child with Burkitt lymphoma.
Childhood Burkitt lymphoma is a fast-growing (high-grade) B-cell non-Hodgkin lymphoma. It is one of the most common lymphomas in children and is defined by a change in the MYC gene, which drives the cancer cells to multiply extremely quickly. A Burkitt tumour can roughly double in size in about a day — faster than almost any other cancer. If your child has just been diagnosed, that speed can feel frightening; the reassuring flip side is that this same fast growth is exactly what makes Burkitt lymphoma so responsive to chemotherapy.
Because it is a form of non-Hodgkin lymphoma in children, it sits within the wider family of childhood lymphomas. It behaves very differently from Hodgkin lymphoma in children and from slower-growing lymphomas, which is why an accurate, tissue-confirmed diagnosis matters so much. For the full picture, start with our overview of lymphoma in children and the general Burkitt lymphoma page.
This guide is written for parents and carers. It explains the signs to watch for, how paediatric Burkitt lymphoma is diagnosed and staged, how it is treated, and what the outlook looks like. Because Burkitt lymphoma bridges lymphoma and childhood-cancer care, your child is supported by both our lymphoma specialists and our paediatric cancer team.
Burkitt lymphoma is one of the fastest-growing human tumours known — its cells can double in number in roughly 24 hours. Counter-intuitively, this rapid growth is why it responds so dramatically to chemotherapy: fast-dividing cells are the most vulnerable to it. This is also why treatment starts promptly and children are monitored closely at the outset. (Source: published paediatric NHL literature, as referenced in NCCN and ESMO non-Hodgkin lymphoma guidelines.)
Symptoms depend on where the lymphoma starts. Because a Burkitt tumour grows over days rather than months, the swelling is often noticeably enlarging.
The most common presentation — a rapidly enlarging, often painless swelling in the abdomen, sometimes with belly pain, a change in bowel habit, or reduced appetite. Burkitt lymphoma frequently begins in the bowel or nearby lymph nodes.
Some children develop fast-growing swelling of the jaw or face. This pattern is seen more often in certain regions and is a classic Burkitt presentation.
Swollen, firm lymph nodes — often in the neck — that are enlarging quickly rather than settling over a week or two as an infected node usually would.
Fever, drenching night sweats, tiredness and unexplained weight loss. On their own these are common and usually harmless, but combined with a fast-growing swelling they warrant urgent review.
Most lumps and swellings in children are not cancer. But a swelling that is enlarging quickly — over days, not months — should be assessed urgently rather than watched. Speak to a CION specialist or call 18002028726.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just received a Burkitt lymphoma diagnosis for your child, want to understand what the stage means, or need a second opinion before treatment begins? CION's team is here.
Confirming Burkitt lymphoma — and mapping exactly how far it has spread — follows a clear, step-by-step pathway. Because the lymphoma grows quickly, CION works to complete this promptly, and delivers the biopsy coordination, bone-marrow exams, imaging and molecular testing directly.
A biopsy — a sample of the tumour or an affected lymph node — is examined under the microscope. Only tissue can confirm the diagnosis and separate Burkitt lymphoma from other childhood lymphomas. Where a swelling is causing pressure symptoms, obtaining tissue is treated as urgent.
On the biopsy, specialised tests look for the characteristic MYC gene rearrangement and B-cell markers such as CD20. These features define Burkitt lymphoma and, importantly, guide the choice of antibody therapy. NCCN and ESMO guidance expect this molecular confirmation as part of a modern paediatric lymphoma work-up.
Staging maps how far the lymphoma has spread. This usually includes a PET-CT or CT scan, a bone-marrow examination, and testing of the spinal fluid, because Burkitt lymphoma can involve the bone marrow and central nervous system. Blood tests also check organ function before treatment. Every child is then reviewed by CION's multidisciplinary tumour board so the plan is agreed by lymphoma, paediatric and supportive-care experts together.
The plan depends on the stage, where the lymphoma has spread and your child's overall health. Every case is reviewed by CION's multidisciplinary tumour board before treatment starts. Because Burkitt lymphoma grows fast, treatment is intensive but relatively short, and the great majority of children do well. The main building blocks are:
The backbone of treatment is multi-agent chemotherapy given in short, intensive blocks over a few months. This exploits the lymphoma's fast growth — the same feature that makes it aggressive also makes it highly sensitive to chemotherapy. CION's team delivers systemic therapy directly. Specific drug combinations are individualised; you can read how plans are structured on our lymphoma treatment in Hyderabad page.
Because Burkitt cells carry the CD20 marker, chemotherapy is usually combined with an anti-CD20 monoclonal antibody, which targets those cells specifically. This immunotherapy is delivered in-house alongside chemotherapy and has improved outcomes for B-cell lymphomas.
Because Burkitt lymphoma can spread to the central nervous system, treatment routinely includes CNS-directed therapy — medicine given into the spinal fluid — to treat or prevent involvement there. This is a standard, planned part of paediatric Burkitt care.
As many cancer cells break down at the start of treatment, a metabolic complication called tumour lysis syndrome can occur. Children are usually admitted for fluids, protective medicines and close monitoring during the first cycle. Nutrition, infection prevention and family support are managed directly by our team throughout.
Most children are cured with first-line treatment. For the small number whose lymphoma comes back, more intensive therapy and, in selected cases, a stem-cell transplant may be considered — transplant is coordinated through accredited partner facilities rather than delivered in-house, with CION managing the surrounding care.
Childhood Burkitt lymphoma has one of the most encouraging outlooks in paediatric oncology. Published series report long-term survival for children with limited-stage disease in roughly the 90% range, with high cure rates even in more advanced stages when treated promptly at experienced centres. Outcomes are strongly linked to starting the right treatment quickly. (Source: NCCN and ESMO paediatric non-Hodgkin lymphoma guidance; figures vary by individual.)
This is understandably the first question most parents ask, and the honest answer is genuinely hopeful. Although Burkitt lymphoma is aggressive, it responds extremely well to modern intensive chemotherapy combined with antibody therapy. Published paediatric series report long-term survival in the region of 90% for children with limited-stage disease, and high cure rates even in more advanced stages treated at experienced centres (per NCCN and ESMO paediatric non-Hodgkin lymphoma guidance).
These are population figures, not a prediction for one child. Your child's individual outlook depends on the stage, how the lymphoma responds to the first cycles of treatment, and overall health — so results vary from child to child. What is consistent is that outcomes are best when treatment begins promptly and is delivered by a coordinated specialist team. CION does not publish its own survival statistics; our role is to explain what the published evidence means for your child and to give you a plan built around healing, with transparent costs. To understand the specialist team who would care for your child, see our best lymphoma doctors in Hyderabad and best lymphoma hospital in Hyderabad pages.
A Burkitt lymphoma diagnosis moves quickly, and a second opinion is especially valuable when:
CION offers a dedicated, free written second-opinion service for families. You deserve a plan built around your child, explained clearly, with costs set out up front. Request your free second opinion or call 18002028726. You can also explore the wider lymphoma hub for related guidance.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if MYC and CD20 testing has not yet been arranged, or if the stage is still unclear.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Childhood Burkitt lymphoma is a fast-growing (high-grade) type of B-cell non-Hodgkin lymphoma. It is one of the most common lymphomas of childhood and is defined by a change in the MYC gene that makes the cancer cells multiply extremely quickly — a Burkitt tumour can double in size in about a day. Despite this rapid growth, it is also one of the most treatment-responsive childhood cancers. Because it grows so fast, it is treated as a medical urgency: a paediatric Burkitt lymphoma diagnosis needs prompt specialist assessment rather than watchful waiting. For the wider picture, see our overview of lymphoma in children and the general Burkitt lymphoma page.
The signs depend on where the lymphoma starts. Many children present with a rapidly enlarging, painless swelling in the abdomen — sometimes with belly pain, a change in bowel habit, or reduced appetite — because Burkitt lymphoma often begins in the bowel or nearby lymph nodes. Others develop fast-growing swelling of the jaw or face, or enlarged neck lymph nodes. General symptoms can include fever, night sweats, tiredness and weight loss. Because a Burkitt tumour grows over days rather than months, any lump or swelling that is enlarging quickly in a child should be assessed urgently. Book a free consultation if you are worried about a fast-growing swelling.
Diagnosis starts with a biopsy — a sample of the tumour or an affected lymph node examined under the microscope. Specialised tests on that tissue look for the characteristic MYC gene rearrangement and B-cell markers such as CD20, which confirm Burkitt lymphoma and separate it from other lymphomas. Staging then maps how far it has spread: this usually includes a PET-CT or CT scan, a bone-marrow examination, and testing of the spinal fluid, because Burkitt lymphoma can involve the bone marrow and central nervous system. CION delivers biopsy coordination, bone-marrow exams, imaging and molecular testing, and every child is reviewed by a multidisciplinary tumour board before treatment is planned.
Because Burkitt lymphoma grows so fast, it is treated with short, intensive blocks of multi-agent chemotherapy given over a few months, usually combined with an anti-CD20 monoclonal antibody. Treatment also protects the brain and spinal fluid, since Burkitt lymphoma can spread there. This approach cures a high proportion of children. Chemotherapy, antibody therapy and supportive care are delivered directly by CION; where a stem-cell transplant is needed for the small number of children who relapse, it is coordinated through accredited partner facilities. Specific drug regimens are individualised by the team — see our lymphoma treatment in Hyderabad page for how plans are built.
The outlook is genuinely encouraging. Although Burkitt lymphoma is aggressive, it responds very well to modern intensive chemotherapy, and published series report long-term survival for children with limited-stage disease in roughly the 90% range, with high cure rates even in more advanced stages treated at experienced centres (per NCCN and ESMO paediatric NHL guidance). Outcomes are best when treatment starts promptly and is delivered by a specialist team. These are population figures — your child's outlook depends on the stage, response to the first cycles and overall health, so individual results vary. Our team will explain what the numbers mean for your child specifically.
It can be, and it is always treated with urgency. Because the tumour doubles roughly every day, a large Burkitt lymphoma can cause problems quickly — bowel obstruction, breathing difficulty from a chest mass, or a metabolic complication called tumour lysis syndrome when many cells break down at the start of treatment. For this reason, children are usually admitted for close monitoring, fluids and protective measures as the first cycle begins. The upside of this fast growth is that Burkitt lymphoma is also very sensitive to chemotherapy. If your child has a rapidly enlarging swelling, do not wait — call our team or request an urgent review.
CION brings paediatric lymphoma care under one coordinated roof: prompt biopsy and bone-marrow assessment, molecular testing for MYC and B-cell markers, PET-CT and spinal-fluid staging, and a multidisciplinary tumour board that reviews every child before treatment. Chemotherapy, antibody therapy, radiation where needed, and supportive care are delivered directly by our team, and complex needs such as transplant are coordinated with accredited partner facilities. Families also get transparent costs and a free written second opinion. Because Burkitt lymphoma bridges lymphoma and childhood-cancer care, families are supported by both our lymphoma specialists and our paediatric cancer team.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.